Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group A Muntañola, T Baumann, AC Caballero, B Sánchez-González, ... Annals of Hematology 99, 1627-1634, 2020 | 6 | 2020 |
Low‐risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study A Muntañola, MT Villalobos, S González‐Villambrosia, ... British Journal of Haematology 202 (4), 776-784, 2023 | | 2023 |
Clinical Characterization, Prognosis and Therapeutic Management of 181 Patients with Splenic Marginal Zone Lymphoma (SMZL): Real World Experience of the Geltamo Group T Villalobos, A Muntañola Prat, S González de Villambrosia, ... Blood 140 (Supplement 1), 9347-9349, 2022 | | 2022 |
Multiple Myeloma (MM) in First Relapse Patients. Role of the Second Autologous stem-cell Trasplant (ASCT) in Real Life. Experience of Two Spanish Centers N Amer, MT Villalobos, R Del Campo, JB Borras, A Porcel, JM Guerra, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 565-566, 2020 | | 2020 |
INDUCTION CHEMOTHERAPY (B-RAM) FOLLOWED BY AUTOLOGOUS TRANSPLANTATION IN PRIMARY CEREBRAL LYMPHOMA (PCL). PRELIMINARY RESULTS OF THE GELTAMO GROUP CLINICAL GUIDE S Mercadal Vilchez, S Bobillo Varela, A Muntanola Prat, P Fernandez, ... HAEMATOLOGICA 104, 94-94, 2019 | | 2019 |
MULTIPLE MYELOMA (MM) IN PRIMARY RELAPSE: ROLE OF THE SECONDARY HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). EXPERIENCE OF TWO CENTRES MT Villalobos, R Del Campo, M Canet, N Amer, P Velez, A Muntanola, ... HAEMATOLOGICA 104, 17-18, 2019 | | 2019 |
Multiple Myeloma (MM) in First Relapse Patients: Role of the Second Autologous Stem-Cell Trasplant (ASCT): Experience of Two Centers T Villalobos, R Del Campo, C Marta, N Amer, V Patricia, M Ana, ... Clinical Lymphoma Myeloma and Leukemia 19 (10), e268, 2019 | | 2019 |